HTSUF Financials: Hisamitsu Pharmaceutical Co Inc AI Analysis

Home

Stock

HTSUF

Financials

HTSUF Financial

Hisamitsu Pharmaceutical Co Inc

$29

At close: Mar 24, 16:00:00 GMT-4

$29

Post-market: Mar 24, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$29

Open

$29

Day's Range

$29 - $29

52 week range

$24.55 - $32.3

Volume

100

Avg.Volume

Dividend yield

EPS (TTM)

1.73

Market Cap

$2.1B

What is HISAMITSU PHARMACEUTICAL CO INC?

Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,799 full-time employees. The firm is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. The company is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. The company is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

HTSUF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	02/28/2025	02/29/2024	02/28/2023	02/28/2022	02/28/2021
Revenue	159,267	156,006	141,706	128,330	120,193	114,510
Revenue Growth (YoY)	6%	10%	10%	7%	5%	-19%
Cost of Revenue	65,224	64,810	62,735	55,630	50,126	45,337
Gross Profit	94,043	91,196	78,971	72,700	70,067	69,173
Selling, General & Admin	75,758	61,397	57,189	51,314	50,117	47,735
Research & Development	--	10,903	8,614	9,785	10,613	10,766
Operating Expenses	75,760	72,301	65,804	61,101	60,730	58,502
Other Non Operating Income (Expenses)	721	731	453	198	418	171
Pretax Income	25,643	28,687	19,186	16,113	12,956	12,197
Income Tax Expense	5,186	6,385	4,754	3,987	3,093	2,764
Net Income	19,988	21,758	13,969	11,742	9,658	9,250
Net Income Growth	28.99%	56%	19%	22%	4%	-51%
Shares Outstanding (Diluted)	70.47	73.71	77	79.4	81.27	81.78
Shares Change (YoY)	-4%	-4%	-3%	-2%	-1%	-1%
EPS (Diluted)	283.61	295.15	181.4	147.87	118.83	113.1
EPS Growth	34%	63%	23%	24%	5%	-50%
Free Cash Flow	--	4,991	5,151	4,820	15,006	1,900
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	59.04%	58.45%	55.72%	56.65%	58.29%	60.4%
Operating Margin	11.47%	12.11%	9.29%	9.03%	7.76%	9.31%
Profit Margin	12.54%	13.94%	9.85%	9.14%	8.03%	8.07%
Free Cash Flow Margin	--	3.19%	3.63%	3.75%	12.48%	1.65%
EBITDA	--	25,230	18,339	16,551	13,658	14,750
EBITDA Margin	--	16.17%	12.94%	12.89%	11.36%	12.88%
D&A For EBITDA	--	6,335	5,172	4,952	4,321	4,079
EBIT	18,283	18,895	13,167	11,599	9,337	10,671
EBIT Margin	11.47%	12.11%	9.29%	9.03%	7.76%	9.31%
Effective Tax Rate	20.22%	22.25%	24.77%	24.74%	23.87%	22.66%

Follow-Up Questions

What are Hisamitsu Pharmaceutical Co Inc's key financial statements?



According to the latest financial statement (Form-10K), Hisamitsu Pharmaceutical Co Inc has a total asset of $343,068, Net profit of $21,758

What are the key financial ratios for HTSUF?



Hisamitsu Pharmaceutical Co Inc's Current ratio is 5.17, has a Net margin is 13.94, sales per share of $2,116.23.

How is Hisamitsu Pharmaceutical Co Inc's revenue broken down by segment or geography?



Hisamitsu Pharmaceutical Co Inc largest revenue segment is Pharmaceuticals, at a revenue of 152,654,000,000 in the most earnings release.For geography, Japan is the primary market for Hisamitsu Pharmaceutical Co Inc, at a revenue of 82,364,000,000.

Is Hisamitsu Pharmaceutical Co Inc profitable?



yes, according to the latest financial statements, Hisamitsu Pharmaceutical Co Inc has a net profit of $21,758

Does Hisamitsu Pharmaceutical Co Inc have any liabilities?



yes, Hisamitsu Pharmaceutical Co Inc has liability of 66,242

How many outstanding shares for Hisamitsu Pharmaceutical Co Inc?



Hisamitsu Pharmaceutical Co Inc has a total outstanding shares of 72.96

Hisamitsu Pharmaceutical Co Inc (HTSUF) Financial

HTSUF Stock Price Chart